FAM177A1

FAM177A1 is a Golgi-associated protein that functions in Golgi membrane dynamics and intersects with inflammatory and mitochondrial signaling pathways (PMID:39331042, PMID:38767059, PMID:41943851). At the Golgi complex it acts as a functional partner of VPS13B: loss of FAM177A1 phenocopies VPS13B knockout by delaying Golgi reformation after Brefeldin A-induced disruption, and fam177a1 genetically interacts with vps13b in zebrafish (PMID:39331042). Loss of FAM177A1 in human fibroblasts and zebrafish dysregulates pathways linked to apoptosis, inflammation, and negative regulation of cell proliferation (PMID:38767059). In immune signaling, FAM177A1 negatively regulates IL-1β-induced NF-κB activation by competitively binding the E3 ubiquitin ligase TRAF6, impairing its interaction with the E2 enzyme Ubc13 and thereby inhibiting TRAF6-mediated polyubiquitination (PMID:34799425). In vascular smooth muscle cells, FAM177A1 disrupts the mitochondrial SIRT3-SOD2 interaction, elevating SOD2 K68 acetylation and mitochondrial ROS while reprogramming metabolism toward glycolysis to drive VSMC phenotypic switching; its deficiency suppresses neointimal hyperplasia and atherosclerosis in animal models (PMID:41943851).

1. 2009 Medium

   Initial characterization established where FAM177A1 (C14orf24) resides and how its expression is controlled, showing it is cytoplasmic, enriched in proliferating cells, and silenced during neuronal differentiation.

   Evidence qRT-PCR, subcellular fractionation, and luciferase reporter assays with miR-124a in P19 cells

   PMID:19663910

   Open questions at the time

   • No molecular function assigned beyond expression pattern
   • miR-124a regulation shown in one cell model only
2. 2021 Medium

   The first defined molecular activity placed FAM177A1 in innate immune signaling as a brake on inflammation, answering how it engages the ubiquitin machinery.

   Evidence Overexpression/knockdown, Co-IP/competitive binding, and NF-κB reporter assays in human cells

   PMID:34799425

   Open questions at the time

   • Single lab, no in vivo confirmation
   • Structural basis of TRAF6 competition not resolved
   • Relationship to Golgi function unclear
3. 2024 Medium

   Subcellular and multi-omic profiling identified FAM177A1 as a Golgi protein whose loss perturbs apoptosis, inflammation, and proliferation programs, linking its localization to broad cellular consequences.

   Evidence Fluorescence microscopy, loss-of-function variants in human fibroblasts and zebrafish, RNA-seq, metabolomics

   PMID:38767059

   Open questions at the time

   • Causal mechanism from Golgi localization to transcriptomic changes not established
   • No direct molecular partner identified in this study
4. 2024 High

   Epistasis and phenocopy experiments defined FAM177A1's Golgi role mechanistically by placing it functionally with VPS13B in Golgi reformation after stress.

   Evidence VPS13B/FAM177A1 KO cell lines, Brefeldin A washout Golgi-reformation assay, zebrafish genetic interaction, super-resolution microscopy

   PMID:39331042

   Open questions at the time

   • Direct physical interaction with VPS13B not biochemically demonstrated
   • Molecular activity of FAM177A1 at the Golgi membrane unknown
5. 2026 Medium

   In vivo disease modeling extended FAM177A1 to mitochondrial regulation, showing it disrupts the SIRT3-SOD2 axis to raise ROS and drive vascular smooth muscle cell phenotypic switching.

   Evidence Fam177a1 KO rats with balloon injury, AAV knockdown mice, ApoE-/- model, Co-IP, acetylation and mitochondrial functional assays

   PMID:41943851

   Open questions at the time

   • How a Golgi protein modulates a mitochondrial interaction is unresolved
   • Single lab, newly published
   • Direct binding of FAM177A1 to SIRT3 or SOD2 not established

• The unifying molecular activity linking FAM177A1's Golgi, immune, and mitochondrial roles remains undefined.
• No biochemical activity or domain function assigned
• Whether the TRAF6, VPS13B, and SIRT3-SOD2 effects share a common mechanism is unknown
• No structural model available